Filing Details

Accession Number:
0001179110-20-001419
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-10 19:24:03
Reporting Period:
2020-02-06
Accepted Time:
2020-02-10 19:24:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
896264 Usana Health Sciences Inc USNA Medicinal Chemicals & Botanical Products (2833) 870500306
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1537768 A. Daniel Macuga 3838 West Parkway Blvd.
Salt Lake City UT 84120
Chief Communications Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-06 873 $0.00 4,969 No 4 M Direct
Common Stock Disposition 2020-02-06 370 $80.71 4,599 No 4 F Direct
Common Stock Acquisiton 2020-02-06 3,470 $70.75 8,069 No 4 M Direct
Common Stock Disposition 2020-02-06 3,470 $80.00 4,599 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 F Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Disposition 2020-02-06 873 $0.00 873 $0.00
Common Stock Stock - Settles Stock Appreciation Right Disposition 2020-02-06 30,000 $0.00 30,000 $70.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
17,784 No 4 M Direct
0 2019-09-01 2020-03-01 No 4 M Direct
Footnotes
  1. Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
  2. On May 1st, 2017, the reporting person was granted restricted stock units, vesting at 25% on each 6th of February thereafter.
  3. The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.